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Most previous studies do not support the
hypothesis that exposure to DDT is an
important risk factor for breast cancer (Lopez-
Cervantes et al. 2004). However, previous
studies were limited by the inability to meas-
ure exposure in young women during periods
of the heaviest DDT use. Consequently
most of these studies observed very low levels
of p,p´-DDT [1,1,1-trichloro-2,2-bis(p-
chlorophenyl)ethane] and o,p´-DDT [1,1,1-
trichloro-2-(p-chlorophenyl)-2-(o-chloro-
phenyl)ethane], the primary constituents of
commercial DDT (Table 1). The conclu-
sions of these studies apply to the effects of
p,p´-DDE [1,1´-dichloro-2,2´-bis(p-chloro-
phenyl)ethylene], the primary metabolite of
p,p´-DDT (Lopez-Cervantes et al. 2004),
which is more persistent in the environment
and in biological systems and can therefore
be measured years after DDT use had
declined (Stehr-Green 1989).
In the present study we investigated
whether serum p,p´-DDT and o,p´-DDT are
associated with breast cancer, using blood
samples obtained before DDT was banned
and when use of this pesticide was very high
(1960s). The median year of blood sampling
in the present study was 1963, not long after
the peak use of DDT in the United States 
in 1959 [U.S. Environmental Protection
Agency (EPA) 1975] and near the peak
dietary content of DDT estimated around
1965 (Wolff et al. 2005). Exposure declined
considerably thereafter, even before the DDT
ban in 1972 (Kutz et al. 1991).
This is the first study to measure blood
levels in young adulthood (mean age of
26 years). In other studies, blood was col-
lected when women were of middle age or
older (Table 1). The present study is also the
first study specifically designed, a priori, to
consider whether age at exposure may mod-
ify DDT effects on breast cancer. Because
DDT was first widely introduced in the
United States beginning in 1945 (U. S. EPA
1975), a woman’s age in 1945 is a proxy for
the youngest possible age at exposure to
DDT and for her age when DDT use was
peaking. A range of ages in 1945 is repre-
sented among women in the Child Health
and Development Studies (CHDS). More-
over, these women could be observed
prospectively. These data permit a unique
design that tests the hypothesis that DDT
associations with breast cancer are larger for
birth cohorts in which women could have
been most heavily exposed in early life.
Materials and Methods
Subjects. Subjects were participants in the
CHDS, residents of the Oakland (California)
area, and members of the Kaiser Permanente
Health Plan who sought obstetric care between
1959 and 1967 (van den Berg et al. 1988).
Subjects voluntarily participated in the
CHDS, giving oral informed consent for an
in-person interview, collection of blood speci-
mens at several points during pregnancy and
early postpartum, and permission for medical-
record access. The present study was reviewed
and approved by the Institutional Review
Board of the Public Health Institute and, we
have complied with all federal guidelines gov-
erning the use of human participants.
Breast cancer cases were identiﬁed by link-
age to the California Cancer Registry and
California Vital Status Records (Cohn et al.
2001). All names for each CHDS subject were
submitted for cancer linkages using ﬁxed (i.e.,
birth date, sex, race, and name) and changeable
(i.e., address and patient record number) iden-
tiﬁers. A rigorous protocol was used to verify
cases, comparing ﬁxed versus changeable iden-
tiﬁers by manual review. The California Cancer
Registry is reported to be > 99% complete after
a lag time of about 2 years (Kwong et al. 2001).
Cases were defined as women with inci-
dent invasive or noninvasive breast cancer
diagnosed before 50 years of age, or deaths
due to breast cancer before age 50, obtained
from linkage conducted in early 1998. A total
of 133 cases met study criteria.
All members of the CHDS cohort are also
linked to the California Department of
Motor Vehicles (DMV) files on a regular
basis to determine residence history, allowing
us to assess their control status and to update
any name changes. All names registered with
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BACKGROUND: Previous studies of DDT and breast cancer assessed exposure later in life when the
breast may not have been vulnerable, after most DDT had been eliminated, and after DDT had
been banned.
OBJECTIVES: We investigated whether DDT exposure in young women during the period of peak
DDT use predicts breast cancer.
METHODS: We conducted a prospective, nested case–control study with a median time to diagnosis
of 17 years using blood samples obtained from young women during 1959–1967. Subjects were
members of the Child Health and Development Studies, Oakland, California, who provided blood
samples 1–3 days after giving birth (mean age, 26 years). Cases (n = 129) developed breast cancer
before the age of 50 years. Controls (n = 129) were matched to cases on birth year. Serum was
assayed for p,p´-DDT, the active ingredient of DDT; o,p´-DDT, a low concentration contaminant;
and p,p´-DDE, the most abundant p,p´-DDT metabolite.
RESULTS: High levels of serum p,p´-DDT predicted a statistically signiﬁcant 5-fold increased risk of
breast cancer among women who were born after 1931. These women were under 14 years of age
in 1945, when DDT came into widespread use, and mostly under 20 years as DDT use peaked.
Women who were not exposed to p,p´-DDT before 14 years of age showed no association between
p,p´-DDT and breast cancer (p = 0.02 for difference by age).
CONCLUSIONS: Exposure to p,p´-DDT early in life may increase breast cancer risk. Many U.S.
women heavily exposed to DDT in childhood have not yet reached 50 years of age. The public
health signiﬁcance of DDT exposure in early life may be large.
KEY WORDS: breast cancer, child health and development studies, exposure timing, o,p´-DDT,
organochlorines, p,p´-DDE, p,p´-DDT, pregnancy, premenopausal. Environ Health Perspect
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Table 1. Studies of blood levels of DDT-related compounds and breast cancer.
Age at diagnosis
Year of Age at blood or percent Cases: p,p´-DDE p,p´-DDT o,p´-DDT p,p´-DDE p,p´-DDT o,p´-DDT
blood draw Place Design draw (years) premenopausal controls association association association (µg/g) (µg/g) (µg/g)
1963 N. California Prospective, 26 100% < 50 years 129:129 None ↑↓ 5.1 1.4 0.06
(CHDS; median  follow-up 65% > LOD
present study) 17 years
1967 N. California Prospective, 45 20% 150:150 None NR NR NRa NR NR
(Krieger mean follow-up
et al. 1994) 14 years
1974 or Maryland Prospective 20% ≤ 40 (1974); NR 340:340 ↓ NR NR “DDE” b NR NR
1989 (Helzlsouer follow-up 2.9% ≤ 40 (1989) 1.7 (1974)
et al. 1999) ≥ 10 years for 70% 1.2 (1989)
1979 Norway (Ward Prospective, 41 60% < 50 years 150:150 None None NR 1.9 (1974) 0.23 (1974) NR
et al. 2000) mean follow-up 1.6 (1976) 0.16 (1976)
9 years 1.0 (1980) 0.10 (1980)
0.44 (1988) 0.02 (1988)
1977 or Copenhagen,  Prospective, 55 (1977) 32% 240:477 None None (1977); NR 1.2 (1977) 0.14 (1977) 20% > LOD
1982 Denmark mean follow-up 60 (1982) 16% 155:274 (Hoyer et al.1998) 1.2 (1982) 0.05 (1982) (1977) (Hoyer
(Hoyer et al. 8 years (1977) ↑ (for average et al. 1998)
1998, 2000)  and 5 years of 1977 and 1982)
(1982) (Hoyer et al. 2000)
1982 Missouri Prospective 57 21%  105:208 None None NR 2.4 0.3 4% > LOD
(Dorgan follow-up
et al. 1999) ≤ 3 years for
half, > 3 to
< 12 years for half
1986 NYC 1986 (Wolff  Prospective, 54 44% 148:295 None NR NR 1.10 NR NR
et al. 2000b) follow-up 
3–9 years
1989 W New York  Retrospective 41–85 0% 154:192 None NR NR 1.15 (Laden  NR NR
(Moysich et al. 1998) et al. 2001)
1990 U.S. nurses Prospective, 59 18% (Laden  372:372 ↓, NS (Hunter NR NR 0.82 NR NR
(Hunter  maximum follow- et al. 2001) et al. 1997);
et al.1997) up 3 years (Hunter  None (Laden
et al.1997); et al.  2001)
extended to 5 years 
(Laden et al. 2001)
1993 Mexico City Retrospective 48 47% 120:126 ↑, more so for None NR 2.51 0·23 NR
(Romieu postmenopausal
et al. 2000) women
1995 NYC 1995 Retrospective 54 37% 175:181 None None NR 0.66 0.03 NR
(Wolff et al.
2000a)
1995 Mexico City Retrospective ~50 50% 141:141 ↓ , NS None NR 0.51 0.08 3% > LOD
(Lopez-Carillo
et al. 1997)
1995 North Carolina, Retrospective 50 (both races) 51% (both races) 292:270 None;↑ among NR NR 1.69 40% > LOD 1% > LOD
African Americans thinnest, 
(Millikan NS
et al. 2000)
1995 North Carolina, Retrospective 50 (both races)  51% (both races) 456:389 ↓, NS NR NR 0.76 40% > LOD 1% > LOD
whites (Millikan
et al. 2000)
1996 Connecticut Retrospective 30–80 17% ≤ 45 years 475:502 None NR NR 0.46 NR NR
(Zheng et al. 2000)
1996 Quebec  Retrospective 53 NR 315:219 or 307 None  None 0.48 0.01 NR
(Demers
et al. 2000)
1996 LI (Gammon Retrospective 24–96 41%  633:418 None None NR 0.65 0.07 NR
et al. 2002)
1997 LA, African Retrospective 49.7 35–64 381:335 None NR NR 1.25 NR NR
Americans
(Gatto et al. 2007)
Abbreviations: ↓, risk declines as DDT compound increases; ↑, risk increases as DDT compound increases; LA, Los Angeles, CA; LI, Long Island, NY; N, northern; NR, not reported; NS, not
statistically signiﬁcant; NYC, New York City; W, western. Only studies that report lipid-adjusted organochlorines are presented, with the exception of Krieger et al. (1994), which is the only
other study conducted with blood samples drawn in the 1960s. Lipid-adjusted organochlorine levels are presented to account for differences in lipid levels for study populations. Median
levels or geometric means for controls are shown when available; otherwise, arithmetic means are presented. Organochlorine levels are not age-adjusted, so some differences by study
population could be due to age differences; most studies reported higher organochlorines in older women. For o,p´-DDT, most studies only report the percentage > LOD, except for the pre-
sent study. The year of blood draw is the median or mean year, and sometimes represents a single year. The age at blood draw is the mean or median reported for cases. If it was not given
or could not be estimated, then the range is shown. For the Quebec study (Demers et al. 2000), two sets of controls were given: the hospital-based controls and the population-based 
controls. 
aLipid-adjusted levels of p,p´-DDE are not available, and p,p´-DDT and o,p´-DDT were not measured. The arithmetic mean concentration of p,p´-DDE was 43 µg/L (Krieger et al. 1994) compared
with the median of 46 µg/L in the present study (CHDS); values are highly comparable because both studies were based on blood samples drawn in the 1960s from N. California women enrolled
in the Kaiser Permanente Health Plan. bHelzlsouer et al. (1999) deﬁned “DDE” as “p,p´-DDT + o,p´-DDT + p,p´-DDE” for the 1974 cohort, and as “p,p´-DDT + p,p´-DDE” for the 1989 cohort. the DMV were used in establishing a match.
Simultaneous linkage of multiple family
members enhanced matching. Regular DMV
matching provides a history of location for
each subject, which we used to determine the
population at risk for cancer, corresponding
with geographic surveillance by California’s
cancer registries. Subjects who could not be
located were considered lost to follow-up at
the date of their last deﬁnitive classiﬁcation as
California residents. One control, matched
exactly on birth year, was selected at random
for each case from those who were under can-
cer surveillance and known to be free of
breast cancer at the age of diagnosis for the
matching case. The median time to diagnosis
for cases was 17 years, and the mean age at
diagnosis was 44 years.
Serum assays. In 2000–2001, we measured
DDT-related compounds in serum samples
that had been collected during 1959–1967.
The mean age of subjects when blood was
drawn was 26 years. Samples collected within
1–3 days of delivery were used for 82% of the
cases and 86% of controls, and serum drawn
during the third trimester was used for the
remainder. Longnecker et al. (1999), reported
that organochlorine levels assayed across all
trimesters of pregnancy and soon after delivery
were highly correlated, indicating that the time
when samples are collected over the 9 months
of pregnancy is not critical. We stored serum
samples at –20°C. Samples were ﬁrst thawed to
prepare an aliquot of 1.5 mL for organochlo-
rine assays. The aliquots were shipped frozen
to the laboratory; p,p´-DDE, o,p´-DDT, and
p,p´-DDT were assayed using methods
reported previously by Gammon et al. (2002).
Sample order was randomly assigned within
and across batches. Case–control pairs were
analyzed in the same batches to minimize dif-
ferences due to laboratory drift. The laboratory
was blind as to case or control status of the sam-
ples. As described previously by Berkowitz et al.
(2003), we used all observed positive values of
o,p´-DDT in analyses, even those reported to
be below the limit of detection (LOD); seven
o,p´-DDT measurements with reported nega-
tive values were recoded as the lowest meas-
ured value (i.e., 0.01 µg/L). Interbatch and
intrabatch coefﬁcients of variation were 16%
and 5%, respectively, for p,p´-DDT; 11% and
4% for p,p´-DDE; and 26% and 5% for
o,p´-DDT. Total cholesterol and total tri-
glycerides were measured enzymatically on a
Hitachi 911 analyzer (Roche Diagnostics,
Indianapolis, IN) in a laboratory certiﬁed by
the Centers for Disease Control and Prevention
(Atlanta, GA) and the National Heart Lung
and Blood Institute Lipid Standardization
Program (Bethesda, MD).
Statistical analysis. Our results are based
on 129 case–control pairs, matched on year of
birth, after excluding 2 pairs with insufﬁcient
serum for lipid assays and 2 pairs with missing
data on body mass index (BMI).
For individuals in 15 pairs for which the
laboratory did not report data for o,p´-DDT,
we imputed o,p´-DDT using analysis of covari-
ance based on year of blood draw, number of
prior pregnancies, breast-feeding, race,
p,p´-DDT, and p,p´-DDE. Findings were sim-
ilar when the 15 pairs with imputed o,p´-DDT
were excluded from analyses (details available
on request from authors). We present results
where these 15 pairs are included.
We considered p,p´-DDT the primary
analysis variable because it is the main con-
stituent of commercial grade DDT. Initial
analyses examined the effect of mutual adjust-
ment for the three DDT-related compounds—
p,p´-DDT, o,p´-DDT, and p,p´-DDE—where
each compound was categorized in tertiles
based on the control population and repre-
sented as two nominal variables: tertile 2 and
tertile 3, where tertile 1 was the reference cate-
gory. We performed data analyses using age-
matched, conditional logistic regression. Breast
cancer associations were compared for the
following models: a) All three DDT-related
compounds entered into the model simultane-
ously (model 1); b) compounds entered two at
a time (model 2); and c) each compound
entered alone (model 3). Based on the likeli-
hood ratio test, we chose the best model for
further examination of study hypotheses.
Trend across tertiles of p,p´-DDT was tested
using a continuous variable.
We examined whether age in 1945 (for
the case–control pair) modified p,p´-DDT
associations with breast cancer. This tested
our a priori hypothesis that exposure to DDT
in childhood and adolescence could increase
susceptibility of the breast to DDT effects.
Because DDT was first used widely in 1945
in the United States (U.S. EPA 1975), age in
1945 was used as a proxy for the youngest age
when a woman could have been exposed. For
example, women born before 1930 were not
exposed during early adolescence, being
> 15 years of age when DDT was ﬁrst intro-
duced. By 1959, the ﬁrst year of CHDS study
enrollment, when DDT use was at its highest,
these women would be 29 years of age.
We coded age in 1945 as a four-category
ordinal variable, defined by quartiles of age
Cohn et al.
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Figure 1. Reported p,p´-DDT (A) and p,p´-DDE (B) levels in blood observed in epidemiologic studies of
breast cancer by year and place of blood draw (note the difference in scales). Abbreviations: LA, Los
Angeles, CA; LI, Long Island, NY; N, northern; NC, North Carolina; NYC, New York City; W, western. Values
shown are median, geometric mean, or arithmetic mean, depending on what was given in the original arti-
cle. Only studies that reported lipid-adjusted levels in blood samples are included because lipids confound
observed levels. 
aPresent study. bWard et al. (2000). cHoyer et al. (1998). dDorgan et al. (1999). eHoyer et al. (2000). fRomieu et al. (2000).
gWolff et al. (2000a). hLopez-Carillo et al. (1997). iGammon et al. (2002). jDemers et al. (2000). kHelzlsouer et al. (1999). lWolff
et al. (2000b). mMoysich et al. (1998). nHunter et al. (1997). oMillikan et al. (2000). pZheng et al. (2000). qGatto et al. (2007).
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NYC 1986 lin 1945 represented in the study sample
(< 4 years, 4–7 years, 8–13 years, and
> 13 years). We estimated odds ratios (ORs)
for p,p´-DDT tertiles within the age quartiles
in 1945, adjusted for year of blood draw and
for o,p´-DDT, coded as an ordinal variable
representing tertiles of o,p´-DDT, coded at
the median values in the control population
(Greenland 1995); values were 0.22, 0.57,
and 0.98 µg/L for tertiles 1, 2, and 3, respec-
tively). o,p´-DDT was included in the model
because it proved to be a confounder of the
p,p´-DDT association.
To evaluate confounding by other meas-
ured breast cancer risk factors, we ﬁt a series of
models that entered one risk variable domain
at a time to avoid adding a large number of
variables to the model. Risk variable domains
were race/ethnicity (African American, Asian,
mixed race, with Caucasian as the reference
category), number of previous pregnancies,
blood lipids (total cholesterol and total triglyc-
erides) (Longnecker et al. 2001), age at first
pregnancy of ≥ 7 months, menarche before
12 years of age (yes or no), BMI [weight/
height2 (kilograms/square meter) measured at
the ﬁrst interview in early pregnancy (coded as
two nominal variables: < 33rd percentile and
> 66th percentile of the control distribution,
or within the 33rd–66th percentiles), and
whether the woman breast-fed after the
observed pregnancy (yes or no).
Results
All subjects had detectable levels of p,p´-DDE
and p,p´-DDT (≥ 0.8 µg/L). Of the subjects,
65% had measurements of o,p´-DDT above
the minimum detectable level of 0.4 µg/L.
Serum levels of p,p´-DDT and p,p´-DDE
were considerably higher in the CHDS popu-
lation than in populations where blood was
sampled one to four decades later (Table 1,
Figure 1).
At the time of blood draw (median year
of 1963), all birth cohorts in the CHDS
sample had been potentially exposed to
DDT for roughly the same number of years
(1945–1963). However, age at first possible
exposure and age at blood sampling differs
considerably among these women (Table 2).
The age in 1945 quartiles represented in the
CHDS population were < 4 years, 4–7 years,
8–13 years, and > 13 years (Table 2), but
blood samples were drawn at a median age of
19 years for women who were youngest in
1945, compared with a median age of
36 years among women who were oldest in
1945 (Table 2). Both difference in age at
exposure and age at blood sampling helps
inform interpretation of findings for these
four groups of women.
Table 3 presents estimates of breast cancer
associations for DDT-related compounds for
women in all age groups in 1945. p,p´-DDT
was associated with increased risk of breast
cancer, whereas o,p´-DDT was associated with
a decreased risk of breast cancer. Adjustment
for o,p´-DDT increased the p,p´-DDT associa-
tion with breast cancer, but adjustment for
p,p´-DDE made little contribution to associa-
tion estimates for p,p´-DDT or o,p´-DDT, nor
was p,p´-DDE significantly, independently
associated with breast cancer.
Table 4 shows estimates of breast cancer
associations for p,p´-DDT according to age in
1945, adjusted for o,p´-DDT and year of
blood draw. There was an excess of p,p´-
DDT in the serum of breast cancer cases a
median of 17 years before diagnosis (p < 0.01
for linear trend; Table 4), but only among
women potentially exposed before 14 years of
age (p = 0.02 for DDT by age interaction;
Table 4). BMI did not account for differences
in p,p´-DDT associations by age in 1945, and
we found no evidence that age in 1945 modi-
ﬁed o,p´-DDT or p,p´-DDE associations with
breast cancer (data not shown).
Table 5 presents associations for DDT-
related compounds in women < 14 years of
age in 1945, which can be compared with
similar models for women of all ages shown
in Table 3. Associations for p,p´-DDT were
stronger in women who were < 14 years of
age in 1945.
DDT and breast cancer 
Environmental Health Perspectives • VOLUME 115 | NUMBER 10 | October 2007 1409
Table 2. Characteristics of study subjects (n = 129 case–control pairs matched on year of birth).
Difference within
Characteristics of controls and cases matched pairs
Variable and 33rd percentile 50th percentile 66th percentile (case – control)
age (years) in 1945a Controls Cases Controls Cases Controls Cases Mean SE
p,p´-DDT (µg/L)
< 4  6.3 9.2 10.9 10.8 13.4 13.1 0.1 1.6
4–7 6.9 7.7 8.4 10.0 13.5 15.8 3.1 2.1
8–13 7.0 8.3 9.4 10.6 12.0 17.4 3.2 2.2
≤ 13 7.0 8.7 9.1 10.6 12.9 14.8 2.1* 1.1
> 13  11.9 9.5 14.0 13.6 18.2 15.4 –2.0 3.2
p,p´-DDE (µg/L)
< 4  33.4 37.9 39.2 44.4 54.3 53.4 2.5 6.5
4–7 34.2 36.3 47.7 48.2 62.5 56.4 2.4 7.1
8–13 29.4 33.8 38.7 40.3 51.4 55.0 4.5 7.2
≤ 13 32.7 36.4 40.7 44.7 54.3 55.0 3.1 4.0
> 13  42.4 36.9 52.8 48.9 61.9 55.7 –5.2 6.6
o,p´-DDT (µg/L)
< 4 0.42 0.47 0.57 0.54 0.73 0.70 0.07 0.15
4–7 0.45 0.39 0.66 0.52 0.79 0.67 –0.07 0.19
8–13 0.42 0.36 0.56 0.50 0.69 0.66 0.05 0.14
≤ 13 0.42 0.39 0.57 0.52 0.74 0.67 0.02 0.09
> 13  0.51 0.39 0.67 0.51 0.84 0.74 –0.23 0.15
Year of blood draw
< 4  1963 1963 1964 1964 1965 1965 0.0 0.4
4–7 1962 1961 1964 1962 1965 1964 –0.9 0.6
8–13 1961 1961 1962 1962 1963 1964 0.1 0.5
≤ 13 1962 1962 1963 1963 1965 1964 –0.2 0.3
> 13  1961 1960 1962 1961 1963 1962 –0.4 0.4
Age at blood draw (years)
< 4  19 19 19 20 20 21 0.0 0.4
4–7 23 22 24 23 25 24 –0.9 0.6
8–13 27 28 29 28 29 29 0.1 0.5
≤ 13 21 21 24 23 26 25 –0.2 0.3
> 13  35 33 36 35 37 36 –0.4 0.4
Age at ﬁrst pregnancy (years)
< 4  18 18 19 19 20 20 0.1 0.5
4–7 21 20 21 21 24 22 –0.7 0.7
8–13 21 24 23 25 24 27 2.0** 1.0
≤ 13 20 20 21 21 23 23 0.5 0.4
> 13  22 23 26 26 29 27 –0.3 1.4
BMI (kg/m2)b
< 4  21 21 22 22 25 24 –1.0 1.1
4–7 21 21 22 23 23 24 0.6 0.7
8–13 21 2 24 23 25 24 0.7 1.0
≤ 13 21 20 22 22 24 23 –0.1 0.6
> 13  21 22 23 23 25 24 –0.2 1.0
No. of previous pregnancies
< 4  0 0 0 0 0 1 0.1 0.1
4–7 0 0 0 1 1 1 –0.1 0.2
8–13 0 0 1 1 2 1 –0.6** 0.2
≤ 13 0 0 0 0 1 1 –0.2* 0.1
> 13  2 2 2 2 3 2 –0.3 0.4
aAge in 1945 corresponds to the earliest possible age of exposure to DDT; categories of age in 1945 (< 4, 4–7, 8–13, and
> 13 years) correspond to quartiles represented in the study sample. bBMI is based on measured weight and height
obtained at an interview conducted in early pregnancy. *p < 0.10, and **p < 0.05 for paired t-test for the hypothesis that
the within-pair difference = 0.Table 6 presents a series of models that
adjust p,p´-DDT and o,p´-DDT associations
for other measured breast cancer risk factors
in women who were < 14 years of age in
1945. There was little evidence of substantial
confounding by any risk variables considered.
Discussion
High levels of serum p,p´-DDT, a median of
17 years before diagnosis, predicted a 5-fold
increased risk of breast cancer among women
who were born after 1931. These women
were < 14 years of age in 1945, the year when
DDT came into widespread use in the United
States. These women would have mostly been
< 20 years of age as DDT use rose to its peak.
Women who were not exposed to p,p´-DDT
before age 14 (born in 1931 or earlier) and
who would have been > 27 years of age when
DDT use peaked, showed no increased risk of
breast cancer according to serum levels of
p,p´-DDT. There was no evidence that any
adjustment variables examined, including
BMI, explained the stronger p,p´-DDT asso-
ciation in women exposed at a young age.
Serum o,p´-DDT is one of the least per-
sistent DDT-related compounds and is an
indicator of recent, active exposure to DDT
(Morgan and Roan 1975). Serum o,p´-DDT
has usually not been studied in relation to
breast cancer (Table 1). In the present study,
we found that serum o,p´-DDT was inversely
associated with breast cancer. This inverse
association may be an indication that expo-
sure to p,p´-DDT that occurred at a younger
age, earlier in time, was the more important
risk factor for breast cancer in this study
population. On average, within o,p´-DDT
tertiles, cases had higher levels of p,p´-DDT
than their matched controls, as evidenced by
the significant p,p´-DDT associations in
models adjusted for o,p´-DDT (Tables 3, 5).
We found no evidence that case–control dif-
ferences in BMI could explain these ﬁndings
(Table 6). Alternatively, the opposing direc-
tion of breast cancer associations for
p,p´-DDT and o,p´-DDT could be explained
by different metabolic pathways and hence
varying exposures to intermediate products of
metabolism. Metabolic studies have shown
that the rate of metabolism of these two com-
pounds differs, with o,p´-DDT eliminated
more quickly (Morgan and Roan 1975).
Our results are consistent with the
hypothesis that p,p´-DDT retained longer,
possibly due to slower metabolism, is the
underlying risk factor for breast cancer in this
population. However, it is impossible to rule
out an alternative explanation—that women at
greatest risk were simply more heavily exposed
at a critical age, some years before their blood
was sampled or during their pregnancy.
Birth cohorts that did not show a
p,p´-DDT association in this study were
older when ﬁrst exposed and also older when
their blood was sampled (Table 2). We can-
not distinguish between the significance of
two factors: a) perhaps the earlier birth
cohorts were not exposed at a vulnerable age;
or b) perhaps we would have detected a
p,p´-DDT effect in the earlier birth cohorts
if we could have measured their exposure at
a younger age. Thus, our findings do not
rule out a p,p´-DDT association for earlier
birth cohorts.
Possible mechanisms. Direct toxicity of
p,p´-DDT, induction of enzymes that produce
other genotoxic intermediates and DNA
adducts, or covariance with another as yet
unknown factor are possible explanations of
the associations we observed. Studies of poly-
chlorinated biphenyls suggest that genetic dif-
ferences in metabolism may interact with body
burden to predict breast cancer risk (Moysich
et al. 1999).
Genotoxicity is one possible mechanism
for the p,p´-DDT association we observed.
However, modern, highly sensitive molecu-
lar methods have only very recently been
used to examine the genotoxicity of DDT in
humans (Yanez et al. 2004).
Direct DNA damage to human blood
cells, possibly with effects on immune surveil-
lance, has received recent attention in studies
of DDT exposure in Mexico, where DDT use
was not banned until 2000 (Perez-Maldonado
et al. 2005, 2006; Yanez et al. 2004). These
authors paired in vitro investigations based on
human blood cells with in vivo investigations
of toxicity in blood samples collected from
women and children in Mexico. Doses tested
in vitro exceeded levels of DDT-related com-
pounds observed in vivo. Nevertheless,
p,p´-DDT and p,p´-DDE were associated
with DNA damage in vivo for women (Yanez
et al. 2004) and children (Perez-Maldonado
et al. 2006), as well as in vitro (Yanez et al.
2004). Perez-Maldonado et al. (2005) sug-
gested that in vitro studies do not accurately
simulate in vivo conditions because humans
are exposed chronically over a long period to
mixtures of p,p´-DDT and its metabolites,
including toxic metabolites other than
p,p´-DDE. The median blood levels of
DDT-related compounds we found in the
present study were higher than average levels
in women living in Mexico (Yanez et al.
2004). Also, the biological significance of
DNA damage associated with DDT-related
compounds is not clear (Yanez et al. 2004).
Further consideration of these exposures in
experimental settings and in human popula-
tions could lead to better understanding of
mechanisms for the associations we observed
in the present study.
Comparison with other studies. The
contrast between ﬁndings in the present study
compared with largely negative results of
Cohn et al.
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Table 3. Associations between DDT-related com-
pounds and breast cancer with and without mutual
adjustment: women of all ages in 1945 (n = 258;
129 case–control pairs matched on year of birth).
Model/variables ORa 95% CI p-Value
Model with all compounds
p,p´-DDT
Tertile 1 1.0 — —
Tertile 2 1.9 0.9–4.1 0.09
Tertile 3 2.9 1.1–8.0 0.04
p,p´-DDE
Tertile 1 1.0 — —
Tertile 2 1.3 0.6–2.7 0.48
Tertile 3 1.0 0.4–2.4 0.92
o,p´-DDT
Tertile 1 1.0 — —
Tertile 2 0.5 0.3–1.0 0.06
Tertile 3 0.4 0.2–0.8 0.02
Models with two compounds
Model 1
p,p´-DDT
Tertile 1 1.0 — —
Tertile 2 2.0 0.9–4.2 0.07
Tertile 3 3.0 1.3–6.8 0.01
o,p´-DDT
Tertile 1 1.0 — —
Tertile 2 0.5 0.3–1.0 0.05
Tertile 3 0.4 0.2–0.8 0.01
Model 2
p,p´-DDT
Tertile 1 1.0 — —
Tertile 2 1.5 0.7–3.0 0.26
Tertile 3 2.0 0.8–5.0 0.14
p,p´-DDE
Tertile 1 1.0 — —
Tertile 2 1.1 0.6–2.3 0.72
Tertile 3 0.7 0.3–1.7 0.40
Model 3
p,p´-DDE
Tertile 1 1.0 — —
Tertile 2 1.8 1.0–3.4 0.06
Tertile 3 1.6 0.8–3.4 0.22
o,p´-DDT
Tertile 1 1.0 — —
Tertile 2 0.6 0.3–1.1 0.11
Tertile 3 0.5 0.3–1.0 0.06
Unadjusted models
p,p´-DDT only
Tertile 1 1.0 —
Tertile 2 1.4 0.7–2.7 0.33
Tertile 3 1.6 0.8–3.0 0.18
p,p´-DDE only
Tertile 1 1.0 —
Tertile 2 1.5 0.8–2.6 0.19
Tertile 3 1.1 0.6–2.0 0.85
o,p´-DDT only
Tertile 1 1.0 — —
Tertile 2 0.7 0.4–1.3 0.22
Tertile 3 0.6 0.4–1.1 0.12
CI, conﬁdence interval. 
aORs were estimated by conditional logistic regression.
p,p´-DDT was represented as two indicator variables, ter-
tile 2 and tertile 3, where tertile 1 was the reference cate-
gory (tertile 1, < 8.09 µg/L; tertile 2, 8.09–13.90 µg/L;
tertile 3, > 13.90 µg/L). o,p´-DDT was represented as two
indicator variables, tertile 2 and tertile 3, where tertile 1
was the reference category (tertile 1, ≤ 0.42 µg/L; tertile 2,
0.43–0.72 µg/L; tertile 3, > 0.72 µg/L). p,p´-DDE was repre-
sented as two indicator variables, tertile 2 and tertile 3,
where tertile 1 was the reference category: tertile 1,
≤ 35.23 µg/L; tertile 2, > 35.23–58.49 µg/L; tertile 3,
> 58.49 µg/L). No variables are included in the models
other than those noted.previous studies can be explained by differ-
ences in study design. There are several rea-
sons for discrepancies between the present
study and most others.
p,p´-DDE as a proxy for DDT. p,p´-DDE
may not be an adequate proxy for exposure to
DDT. Commercial grade DDT consists pri-
marily of p,p´-DDT, as well as a low concen-
tration of o,p´-DDT. Neither of these
compounds are as persistent as p,p´-DDE, a
highly lipophilic metabolite formed from
p,p´-DDT (Morgan and Roan 1975; Stehr-
Green 1989). Humans form p,p´-DDE from
p,p´-DDT particularly during periods of active
exposure to commercial DDT (Morgan and
Roan 1975). However, humans also ingest
p,p´-DDE directly, as it is present in foods
containing animal fat and is more persistent
than its parent compound (Longnecker et al.
1997). Thus, p,p´-DDE levels in human serum
may not accurately reflect past exposure to
p,p´-DDT, particularly when blood samples
are obtained decades after exposure to
p,p´-DDT. Moreover, individual differences in
metabolism and body fatness may further com-
plicate the interpretation of serum levels of
p,p´-DDE in serum samples obtained long
after direct exposure to DDT (Perry et al.
2005; Wolff and Anderson 1999; Wolff et al.
2005). There is prior empirical evidence that
p,p´-DDT exposure may not be meaningfully
approximated by p,p´-DDE in human serum.
The ratio of these compounds in human serum
is variable, and a higher level of p,p´-DDT for
a given level of p,p´-DDE has been reported to
be associated with adverse outcomes, including
longer time to pregnancy in daughters exposed
in utero (Cohn et al. 2003) and primary liver
cancer (McGlynn et al. 2006).
Varied biologic activity. Various DDT-
related compounds do not have the same bio-
logic activity. The compound p,p´-DDE acts
as an antiandrogen but not as an estrogen;
o,p´-DDT acts as an extremely weak estrogen;
and p,p´-DDT shows little or no androgenic
or estrogenic activity (Kelce et al. 1995).
Thus, it is not likely that the p,p´-DDT asso-
ciation that we observed is due to estrogenic
or androgenic activity. Moreover, it is reason-
able to expect that the effects of these three
compounds differ. Few prior studies measured
all three compounds or considered all three
compounds simultaneously (Table 1).
Exposure at critical periods. Prior human
studies have not measured exposure during
critical periods of susceptibility (Birnbaum
and Fenton 2003). For the human breast, the
critical periods appear to be during fetal life,
adolescence, and early reproductive life, par-
ticularly before the ﬁrst full-term pregnancy.
Radiation, an established environmental risk
factor for breast cancer, increases breast can-
cer risk most strongly when exposures occur
early in life (Howe and McLaughlin 1996).
Atomic bomb survivors < 20 years of age had
the greatest excess risk of breast cancer
(Tokunaga et al. 1994). These findings are
consistent with rodent studies which show
that effects of environmental exposures
depend on whether the exposure occurs 
during critical periods of mammary develop-
ment (in utero, during puberty, or during
pregnancy) (Fenton 2006).
Influence of blood-sampling year. The
year of blood sampling may influence the
strength of DDT associations with breast can-
cer. In nearly all earlier studies, blood samples
were collected in the mid-1970s and most
much later, well after exposure to p,p´-DDT
or o,p´-DDT could be directly observed for
most women (Table 1, Figure 1). Only one
previous study was based on samples col-
lected during years of heavier DDT use (the
1960s), but p,p´-DDT and o,p´-DDT were
not measured (Krieger et al. 1994). That
study reported no overall association between
p,p´-DDE and breast cancer (Table 1), which
is consistent with the present study.
The U.S. EPA (1975) estimated that the
maximum use of DDT occurred in 1959,
and dietary DDT is estimated to have
peaked around 1965 (Wolff et al. 2005). In
the Second National Health and Nutrition
Examination Survey, conducted between
1976 and 1980, o,p´-DDT was detectable in
only 0.4% of human serum samples, whereas
p,p´-DDT was detectable in 37.5% of sam-
ples (Stehr-Green 1989). In contrast,
p,p´-DDE was detectable in 99.5% of these
samples. These survey data are consistent
with early metabolic studies which reported
that the rates of elimination for DDT-related
compounds differ considerably. Humans
eliminate o,p´-DDT most rapidly, followed
by p,p´-DDT, and then p,p´-DDE (Morgan
and Roan 1975).
Age at diagnosis. Most previous studies
have included both premenopausal and post-
menopausal cases (Table 1), but even studies
that did stratify ﬁndings by age at diagnosis
did not ﬁnd signiﬁcant breast cancer associa-
tions for p,p´-DDT or p,p´-DDE in younger
or premenopausal women (Gammon et al.
2002; Lopez-Carillo et al. 1997; Romieu
et al. 2000). We speculate that these studies
share a common limitation, namely that
reported levels of p,p´-DDT observed were
much lower than those found in the present
study (Table 1, Figure 1). Studies conducted
with blood samples drawn in the 1970s and
later could be more subject to misclassiﬁca-
tion of early life exposure because of sam-
pling well after peak DDT exposure
(Figure 1).
Age at blood sampling. Most prior stud-
ies were based on blood samples that were
obtained from middle-aged or older women
(Table 1), whereas in the present study blood
samples were obtained at a mean age of
26 years. Accordingly, the failure to observe
increased risk in earlier studies where
p,p´-DDT was measured may be explained if
the breast is vulnerable to the cancer-promot-
ing effects of DDT only during early breast
growth and development.
Age at exposure. We found that serum
p,p´-DDT was associated with breast cancer
only for women potentially exposed at a young
age (before 14 years of age). These women
would also have been mostly < 20 years of age
when DDT use peaked. This ﬁnding is con-
sistent with results obtained in studies of
exposure to atomic bomb radiation, where
excess risk of breast cancer was observed
DDT and breast cancer 
Environmental Health Perspectives • VOLUME 115 | NUMBER 10 | October 2007 1411
Table 4. p,p´-DDT association with breast cancer stratiﬁed by the age of each case–control pair in 1945, the year DDT became widely used in the United States.
Age quartile 1 Age quartile 2 Age quartile 3 Age quartile 4 Age quartiles 1–3
All ages < 4 years  4–7 years  8–13 years ≥ 14 years < 14 years
p,p´-DDT level OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Tertile1 1.0 — 1.0 — 1.0 — 1.0 — 1.0 — 1.0 —
Tertile 2 1.9* 0.9–4.0 7.0* 0.9–55.5  4.1 0.6–29.3 1.4 0.4–5.4 0.7 0.1–3.3 2.8** 1.1–6.8
Tertile 3 2.8** 1.2–6.7 11.5* 1.0–138.9 9.6 0.7–137.2 3.9 0.8–19.2 0.6 0.1–3.2 5.4# 1.7–17.1
p-Value for trenda 0.01
p-Value for interaction between p,p’ DDT and age in 1945b 0.02
CI, confidence interval. All age groups include 258 subjects (129 case–control pairs) matched on year of birth. Categories of age in 1945 correspond to age quartiles in this sample.
Quartiles 1–4 consist of 34 case–control pairs, 29 case–control pairs, 33 case–control pairs, and 33 case–control pairs, respectively. Uneven numbers by quartile result from the age dis-
tribution in the sample. ORs were estimated by conditional logistic regression models within subsets shown, matched on year of birth. Models included year of blood draw; p,p´-DDT
represented as two indicator variables, tertile 2 and tertile 3, where tertile 1 was the reference category based on the distribution in the control population (tertile 1, < 8.09 µg/L; tertile 2,
8.09–13.90 µg/L; tertile 3, > 13.90 µg/L); and, o,p´-DDT was represented as a three category ordinal variable based on tertiles of the control population and coded at tertile medians of the
control population (0.22 µg/L, 0.57 µg/L, and 0.98 µg/L for tertiles 1, 2, and 3, respectively.
aBased on p,p´-DDT coded as a continuous variable in a conditional logistic model, adjusted as described above. bEstimated by a product term between a dichotomous variable for age
in 1945 (< 14 years vs. ≥ 14 years) and p,p’ DDT (continuous variable) in conditional logistic model adjusted as described above. *p < 0.10. **p < 0.05. #p < 0.01.Cohn et al.
1412 VOLUME 115 | NUMBER 10 | October 2007 • Environmental Health Perspectives
Table 6. p,p´-DDT association with breast cancer before and after adjustment for other risk factors:
women < 14 years of age in 1945.
Model/variables OR 95% CI p-Value
Model 1
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 2.8 1.1–6.8 0.03
p,p´-DDT tertile 3 5.4 1.7–17.2 0.00
o,p´-DDT (tertile 3 vs. tertile 1) 0.3 0.1–0.7 0.00
Year of blood draw 1.0 0.8–1.2 0.97
Model 2
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 2.7 1.1–6.8 0.03
p,p´-DDT tertile 3 5.4 1.7–17.3 0.00
o,p´-DDT (tertile 3 vs. tertile 1) 0.3 0.1–0.7 0.01
Year of blood draw 1.0 0.9–1.2 0.88
No. of previous pregnancies 0.8 0.5–1.2 0.23
Model 3
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 3.0 1.2–7.4 0.02
p,p´-DDT tertile 3 6.7 1.9–24.1 0.00
o,p´-DDT (tertile 3 vs. tertile 1) 0.3 0.1–0.6 0.00
Year of blood draw 1.0 0.9–1.2 0.88
Total cholesterol (mg/dl) 1.0 1.0–1.0 0.53
Total triglycerides (mg/dl) 1.0 1.0–1.0 0.95
Model 4
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 2.8 1.1–7.0 0.02
p,p´-DDT tertile 3 5.8 1.8–19.0 0.00
o,p´-DDT (tertile 3 vs. tertile 1) 0.3 0.1–0.7 0.00
Year of blood draw 1.0 0.8–1.2 1.00
BMI tertile 1a 1.3 0.6–2.8 0.58
BMI tertile 3a 1.2 0.5–2.5 0.70
Model 5
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 2.7 1.1–6.6 0.04
p,p´-DDT tertile 3 5.4 1.7–17.7 0.01
o,p´-DDT (tertile 3 vs. tertile 1) 0.3 0.1–0.7 0.01
Year of blood draw 0.9 0.8–1.1 0.50
Age at ﬁrst pregnancy (years) 1.1 1.0–1.2 0.18
Model 6
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 2.8 1.1–7.1 0.03
p,p´-DDT tertile 3 5.4 1.7–17.1 0.00
o,p´-DDT (tertile 3 vs. tertile 1) 0.3 0.1–0.7 0.00
Year of blood draw 1.0 0.8–1.2 0.92
Menarche before age 12 1.1 0.6–2.3 0.74
Model 7
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 3.1 1.2–8.2 0.02
p,p´-DDT tertile 3 7.3 2.1–26.0 0.00
o,p´-DDT (tertile 3 vs. tertile 1) 0.2 0.1–0.6 0.00
Year of blood draw 1.0 0.9–1.2 0.61
African Americanb 0.9 0.4–2.0 0.75
Asianb 0.1 0.0–1.3 0.08
Mixed raceb 1.7 0.6–5.3 0.35
Model 8
p,p´-DDT tertile 1 1.0 — —
p,p´-DDT tertile 2 3.0 1.2–7.7 0.02
p,p´-DDT tertile 3 6.4 1.9–21.5 0.00
o,p´-DDT (tertile 3 vs. tertile 1) 0.3 0.1–0.7 0.00
Year of blood draw 1.0 0.8–1.2 0.96
Breast-feeding in observed pregnancy 1.4 0.8–2.8 0.27
(yes vs. no)
CI, conﬁdence interval. ORs were estimated by conditional logistic regression. Each model is based on 192 subjects rep-
resenting 96 case–control pairs matched on year of birth. p,p´-DDT was represented as two indicator variables, tertile 2
and tertile 3 where tertile 1 was the reference category (tertile 1, < 8.09 µg/L; tertile 2, 8.09–13.90 µg/L; tertile 3,
> 13.90 µg/L). o,p´-DDT was represented as a three-category ordinal variable based on tertiles in the control population
(tertile 1, ≤ 0.42 µg/L; tertile 2, 0.43–0.72 µg/L; tertile 3, > 0.72 µg/L) and coded at the median value within each tertile
(0.22 µg/L, 0.57 µg/L, and 0.98 µg/L for tertiles 1, 2, and 3, respectively). ORs for o,p´-DDT are given for difference between
the median in the third tertile and the median in the ﬁrst tertile (0.76 µg/L). Model 1 is also shown in Table 4 (right-hand
column; age quartiles 1–3, < 14 years) and is provided here to allow comparison with estimates after adjustment for other
breast cancer risk factors. 
aReference category is 33rd–66th percentiles of BMI (kg/m2). Percentiles are based on distribution of body mass in con-
trols. The 33rd and 66th percentiles were deﬁned as ≤ 21.23 kg/m2 and > 23.71 kg/m2, respectively. bReference category is
Caucasian.
Table 5. Associations between DDT-related com-
pounds and breast cancer with and without mutual
adjustment: women < 14 years of age in 1945
(n = 192, 96 case–control pairs matched on year of
birth).
Model/variables ORa 95% CI p-Value
Model with all compounds
p,p´-DDT
Tertile 1 1.0 — —
Tertile 2 2.5 1.0–6.3 0.05
Tertile 3 5.2 1.4–19.1 0.01
p,p´-DDE
Tertile 1 1.0 — —
Tertile 2 1.5 0.6–3.4 0.34
Tertile 3 0.9 0.3–3.0 0.90
o,p´-DDT
Tertile 1 1.0 — —
Tertile 2 0.5 0.2–1.2 0.13
Tertile 3 0.3 0.1–0.7 0.01
Models with two compounds
Model 1
p,p´-DDT
Tertile 1 1.0 — —
Tertile 2 2.6 1.1–6.4 0.04
Tertile 3 5.0 1.7–14.8 0.00
o,p´-DDT
Tertile 1 1.0 — —
Tertile 2 0.5 0.2–1.2 0.12
Tertile 3 0.3 0.1–0.7 0.01
Model 2
p,p´-DDT
Tertile 1 1.0 — —
Tertile 2 1.7 0.8–3.8 0.18
Tertile 3 2.9 0.9–9.1 0.06
p,p´-DDE
Tertile 1 1.0 — —
Tertile 2 1.3 0.6–2.7 0.56
Tertile 3 0.6 0.2–1.7 0.32
Model 3
p,p´-DDE
Tertile 1 1.0 — —
Tertile 2 2.2 1.0–4.8 0.04
Tertile 3 2.1 0.8–5.2 0.12
o,p´-DDT
Tertile 1 1.0 — —
Tertile 2 0.6 0.3–1.4 0.21
Tertile 3 0.4 0.2–1.0 0.06
Unadjusted models
p,p´-DDT only
Tertile 1 1.0 — —
Tertile 2 1.5 0.7–3.2 0.25
Tertile 3 1.9 0.9–4.2 0.09
p,p´-DDE only
Tertile 1 1.0 — —
Tertile 2 1.7 0.9–3.5 0.12
Tertile 3 1.2 0.6–2.4 0.62
o,p´-DDT only
Tertile 1 1.0 — —
Tertile 2 0.8 0.4–1.7 0.59
Tertile 3 0.6 0.3–1.2 0.18
CI, conﬁdence interval. 
aORs were estimated by conditional logistic regression.
p,p´-DDT was represented as two indicator variables; ter-
tile 2 and tertile 3, where tertile 1 was the reference cate-
gory (tertile 1, < 8.09 µg/L; tertile 2, 8.09–13.90 µg/L;
tertile 3, > 13.90 µg/L). o,p´-DDT was represented as two
indicator variables, tertile 2 and tertile 3, where tertile 1
was the reference category (tertile 1, ≤ 0.42 µg/L; tertile 2,
0.43–0.72 µg/L; tertile 3, > 0.72 µg/L). p,p´-DDE was repre-
sented as two indicator variables, tertile 2 and tertile 3,
where tertile 1 was the reference category (tertile 1,
≤ 35.23 µg/L; tertile 2, > 35.23–58.49 µg/L; tertile 3,
> 58.49 µg/L). No variables are included in the models
other than those noted. primarily in women who were young at the
time of exposure (Tokunaga et al. 1994).
Limitations of the present study. We were
unable to sample serum serially by age to
determine more precisely when the body
burden of DDT-related compounds was
acquired. However, our ﬁndings support the
hypothesis that initial exposure to p,p´-DDT
during a critical period in early life is more
important for breast cancer development
than chronic exposure to its metabolite,
p,p´-DDE. As found in several earlier stud-
ies (e.g., Lopez-Cervantes et al. 2004),
p,p´-DDE was not related to breast cancer
in this study population.
We could not determine how women
acquired their exposure to DDT. However,
we had information on farm residence in early
life for 70% of our subjects because this ques-
tion was added to a later revision of the intake
interview. Among those with available infor-
mation, 78% of cases and 74% of controls
reported no residence on a farm, suggesting
that most DDT exposure occurred in the con-
text of urban life, probably through diet and
direct contact for insect control.
We lack information on risk factors
between the time of the pregnancy we observed
and the subsequent development of breast can-
cer; thus, we were not able to fully adjust for
completed parity, lifetime lactation, or ﬂuctua-
tions in weight before or after the blood draw.
However, we were able to adjust for BMI in
early pregnancy, breast-feeding following the
observed pregnancy, and age at ﬁrst pregnancy
(one of the strongest reproductive risk factors
for breast cancer).
Lactation after the observed pregnancy,
which we could measure, may have helped
clear lipophilic DDT-related compounds
acquired in early life and may be more relevant
to our hypothesis. Lactation was not a risk fac-
tor for breast cancer, and any clearance of
p,p´-DDT due to lactation after the observed
pregnancy did not appear to confound the
p,p´-DDT association with breast cancer
(Table 6). However, breast-feeding was rare
and short-term among women in this study;
only 34% of women breast-fed, and among
those who did, 60% breast-fed for < 4 months.
In a previous study of postmenopausal breast
cancer, Moysich et al. (1998) found evidence
supporting a stronger association for body bur-
den of organochlorines among parous women
who had never lactated, suggesting that lacta-
tion could help protect the breast. We did not
see this interaction. The difference could be
that our study measured exposure at a much
younger age in relation to premenopausal
breast cancer, which may have been initiated
earlier in life.
It is possible that our method for adjusting
for serum lipids may be imperfect and could
also result in some residual confounding.
Unmeasured and unknown confounders
remain an alternative explanation of our
ﬁndings.
We suggest that the higher serum levels of
DDT-related compounds observed in the
present study (Figure 1) are due to blood col-
lection during peak, active DDT exposure.
We have supported this interpretation by cit-
ing reports of declines in DDT-related com-
pounds in human samples as DDT use
declined. However, it is possible that popula-
tion differences in lactation history or other
factors could contribute to the differences
seen in Figure 1.
Our study is limited by a relatively small
sample size, and replication will be difficult
because populations with samples obtained
from young women during active DDT use
are scarce. Follow-up of populations in coun-
tries with more recent and heavy use of DDT
could provide new information. Timely sam-
ple collection during active exposure, in a
population with a wide range of exposure,
may increase power to detect effects even in
small studies. For example, a study of dioxin
exposure based on 15 cases in a cohort of
981 women accidentally exposed in Seveso,
Italy, reported a significant dioxin effect on
breast cancer (Warner et al. 2002).
The sample size for the present study
might be considered a possible explanation of
negative findings. However, the strong and
statistically significant effect observed for
p,p´-DDT (OR 5.4; p < 0.01) is of more
interest given the sample size. Although the
effect estimate was not precise [95% confi-
dence interval (CI), 1.7–17.1; Table 4], the
public health signiﬁcance of DDT exposure is
potentially large, even if the effect is actually
closer to the lower limit of the 95% CI. This
is because of the ubiquitous nature of DDT
exposure.
Conclusion
It is too soon to decide that DDT exposure has
little public health signiﬁcance for breast cancer
risk. We base this conclusion on a) the long
latency of possible effects on breast cancer;
b) the large numbers of women exposed world-
wide; and c) the evidence that we provide here
which suggests that women exposed at a young
age may be most strongly affected. Women
born in the late 1950s and 1960s who were
heavily exposed when young have not yet
reached 50 years of age, let alone the age of
greatest breast cancer risk.
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